Back to search results

Neoadjuvant Tebentafusp for Uveal Melanoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Locally Advanced Unresectable Uveal Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Rino Seedor, MD) · rino.seedor@jefferson.edu · 215-955-8874
    Contact: Principal Investigator (Rino Seedor, MD)

  • Wills Eye Hospital, Philadelphia, Pennsylvania, United States

Study leads

  • Rino Seedor, MD

    Principal Investigator

    Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)